Skip to main content
. 2018 Apr 6;9:320. doi: 10.3389/fphar.2018.00320

Table 3.

Association values between gene polymorphisms and clinical parameters.

Polymorphism N BMI Diagnosis age HbA1c
ABCC8-Ala1369Ser
A/A 180 30.74 ± 6.84 46.23 ± 11.37 8.69 ± 2.07Δ
A/C 241 29.84 ± 5.93 45.16 ± 11.34 8.34 ± 2.21
C/C 74 29.44 ± 5.26 43.20 ± 9.52 8.74 ± 2.09
A/A+C/C 254 30.36 ± 6.44 45.35 ± 10.93 8.70 ± 2.07Inline graphic
CYP2C9-Arg144Cys
C/C 423 30.07 ± 6.26 45.41 ± 11.03 8.49 ± 2.17
C/T 67 30.30 ± 6.04 44.69 ± 11.40 8.67 ± 2.00
T/T 5 30.17 ± 2.09 40.00 ± 16.33 9.60 ± 2.13
CYP2C9-Ile359Leu
A/A 460 30.06 ± 6.01 45.35 ± 10.96 8.52 ± 2.13
C/A 35 30.67 ± 8.28 44.06 ± 13.24 8.55 ± 2.34
KCNJ11-Glu23Lys
C/C 179 30.70 ± 6.87 46.26 ± 11.56 8.64 ± 2.08
C/T 246 29.91 ± 5.96 44.95 ± 11.25 8.37 ± 2.19
T/T 70 29.26 ± 5.01 43.79 ± 9.28 8.75 ± 2.13
C/C+T/T 249 30.29 ± 6.42 45.56 ± 11.00 8.67 ± 2.09£
KCNJ11-Ile1337Val
C/C 71 29.36 ± 5.05 43.75 ± 9.22 8.74 ± 2.12
C/T 247 29.97 ± 6.17 44.91 ± 11.34 8.38 ± 2.20
T/T 177 30.59 ± 6.62 46.34 ± 11.46 8.64 ± 2.07
SLC22A1-Arg61Cys
C/C 475 30.05 ± 6.21 45.40 ± 11.03 8.53 ± 2.16
C/T 20 31.43 ± 5.83 41.90 ± 13.02 8.51 ± 1.77
SLC22A1-Met61Val
G/G 92 30.77 ± 6.22 46.41 ± 9.96 8.18 ± 2.04
A/G 26 29.74 ± 4.45 45.58 ± 14.77 8.14 ± 1.74
A/A 6 28.66 ± 4.03 43.67 ± 10.65 8.15 ± 1.83
SLC22A2-Ala270Ser
A/C 58 30.04 ± 6.35 46.03 ± 11.17 8.04 ± 1.56
C/C 437 30.11 ± 6.18 45.15 ± 11.12 8.59 ± 2.20
SLC22A2-Met420Del
ATG/ATG 52 30.56 ± 6.30 44.65 ± 9.87 8.35 ± 2.09
ATG/delTGA 49 30.72 ± 5.77 48.10 ± 12.73 8.05 ± 2.00
delGAT/delGAT 23 29.61 ± 4.78 45.13 ± 9.59 8.02 ± 1.56

Data presented as mean ± SD. BMI: body mass index; HbA1c: hemoglobin A1c. ΔP = 0.029 (A/A vs. A/C), Inline graphicp = 0.012 (A/A+C/C vs. A/C), and £p = 0.039 (C/C+T/T vs. C/T).